CSO & Co-founder
Peter Wostyn, MD, received his medical training at the Faculty of Medicine, University of Leuven, Leuven, Belgium. His research interests focus on the role of intracranial pressure and the glymphatic system in the development of Alzheimer’s disease, Glaucoma and Spaceflight-associated neuro-ocular syndrome.
The theoretical parts of the glymphatic hypothesis of Glaucoma and Spaceflight-associated neuro-ocular syndrome were first developed and introduced in his papers published in Fluids and Barriers of the CNS (2015), Aerospace Medicine and Human Performance (2018) and Eye-Nature (2019).
He is a reviewer for several academic journals.
He is the inventor of pending patent applications pertaining to glaucoma and Alzheimer’s disease treatment using an intrathecal cerebrospinal fluid pump system, and pertaining biomarkers for spaceflight-associated neuro-ocular syndrome.
- Scientific management